News

Every day, doctors across various specialties diagnose cases of inflammatory arthritis, enteropathy, hyperinsulinemic ...
Researchers reviewed the potential for links between age-related macular degeneration and immune-mediated inflammatory ...
Immunocore reports first quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $93.9 million in Q1 2025, growing by 33% year-over-year ...
Graft vs. host disease (GVHD) is a serious condition that can occur after a stem cell transplant from a donor, where the ...
The Italian study showed that patients with HCC resulting from viral infections or fatty liver had significantly higher ...
Learn about celiac disease causes, symptoms, diagnosis, and gluten-free treatment options in this easy-to-understand guide.
Two years after receiving an investigational gene therapy as part of a clinical trial co-led by UCLA’s Dr. Donald Kohn, nine children born with a life-threatening immune disorder are living free of ...
Immunocore Holdings' stock has dropped 60% as Kimmtrak faces market saturation, but its pipeline could offer potential. Find out why IMCR stock is a hold.
In the early stages of this rare hereditary disease the brain appears to play a major role by over-activating the immune system, as shown by a recent study. Patients with spastic paraplegia type ...
Based in Basel, Granite Bio has emerged from stealth with a focus on developing first-in-class antibodies targeting multiple autoimmune diseases. The company has secured $100 million in two funding ...
Brain tissue analysis of an animal model has revealed the potential role of immune system dysfunction in the onset and progression of Alzheimer's disease (AD). Published April 15, 2025 in the ...